Sulfacytine
Generic Name: sulfacytine
Manufactured by GLENWOOD. Dosage form: TABLET. Route: ORAL. Active ingredients: SULFACYTINE (250MG). Application: NDA017569.
Overview
Manufactured by GLENWOOD. Dosage form: TABLET. Route: ORAL. Active ingredients: SULFACYTINE (250MG). Application: NDA017569.
Dosage
Available as tablet for oral use.
Related Medications
Aflibercept
aflibercept
Vascular Endothelial Growth Factor Inhibitor [EPC]
11 DESCRIPTION Aflibercept is a recombinant fusion protein consisting of portions of human VEGF receptors 1 and 2 extracellular domains fused to the Fc portion of human IgG1 formulated as an iso-osmotic solution for intravitreal administration. Aflibercept is a dimeric glycoprotein with a protein molecular weight of 97 kilodaltons (kDa) and contains glycosylation, constituting an additional 15% of the total molecular mass, resulting in a total molecular weight of 115 kDa.
Levetiracetam Injection
levetiracetam injection
11 DESCRIPTION Levetiracetam in Sodium Chloride Injection is an antiepileptic drug available as a clear, colorless, sterile solution for intravenous administration. The chemical name of levetiracetam, a single enantiomer, is (-)-(S)-α-ethyl-2-oxo-1-pyrrolidine acetamide, its molecular formula is C8H14N2O2 and its molecular weight is 170.21. Levetiracetam is chemically unrelated to existing antiepileptic drugs (AEDs).
Cimicifuga, Drosera, Formica Rufa, Fuligo, Inula Hel., Kali Mur, Lapis Albus, Silicea
cimicifuga, drosera, formica rufa, fuligo, inula hel., kali mur, lapis albus, silicea
For detail, please read the enclosed package (product information leaflet)
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.